Curcumin as "Curecumin": from kitchen to clinic.
By A. Goel, A. Kunnumakkara, Bharat B. Aggarwal. Biochemical Pharmacology, 2008
2,203 citations recorded by the source corpus.
Subfields: Molecular Biology, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/b0accd2b4280fe4f8ef93640917c75643aa1928f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Bharat B. Aggarwal
- Subash C. Gupta
- K. Harikumar
- Bokyung Sung
- P. Anand
- S. Prasad
- A. Kunnumakkara
- Julie S. Jurenka
In Molecular Medicine
- Bharat B. Aggarwal
- S. Prasad
- Bokyung Sung
- A. Kunnumakkara
- P. Anand
- K. Harikumar
- Subash C. Gupta
- Raghavendhar R. Kotha
In Pharmacology
- Bharat B. Aggarwal
- P. Anand
- Bokyung Sung
- Raghavendhar R. Kotha
- Devanand L. Luthria
- A. Kunnumakkara
- S. Prasad
- Subash C. Gupta
Citations in the corpus
- Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases (2008, background): “Various clinical trials with curcumin, those that have been completed and those that are ongoing have been recently reviewed (Goel et al., 2008).”
- Natural products and drug discovery (2009, background): “First, some natural compounds— for example, curcumin, resveratrol or quercetin—can bind to many target molecules implicated in human disease (Aggarwal & Shishodia, 2006; Goel et al, 2008; Ji & Zhang, 2008).”
- Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. (2008, background): “*Note: FAP, familial adenomatous polyposis; ACF, aberrant crypt foci; FAD, focal areas of dysplasia; B[a]P, benzo[a]pyrene; DMBA, 7,12dimethylbenz[a]nthracene; TPA, 12-O-tetradecanoylphorbol-13-acetate; NNK, 4-(methyl-nitrosamino)-I-(3-pyridyl)-1-butanone; NQO, 4-nitroquinoline 1-oxidase; DMAB, 3,20”
- Design of Curcumin Loaded PLGA Nanoparticles Formulation with Enhanced Cellular Uptake, and Increased Bioactivity in vitro and Superior Bioavailability in vivo (2009, positive): “Animal studies have revealed that curcumin can prevent carcinogen-induced tumorigenesis and inhibit growth of implanted human tumors [3,11].”
- Bactericidal Activity of Curcumin I Is Associated with Damaging of Bacterial Membrane (2015, background): “Curcumin I showed no toxic effect on human health even when taken at doses as high as 8 g day [18, 2].”
- Curcumin and cancer: an "old-age" disease with an "age-old" solution. (2008, background): “Liposomal curcumin down-regulated NF-jB machinery, suppressed growth and induced apoptosis of human pancreatic cells in vitro [2].”
- Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. (2008, background): “The active part of the [6]gingerol molecule in mutagenesis.”
- Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects (2019, background): “CUR downregulates the signal transducer and activation transcription (STAT) proteins, which are essential for cell growth, differentiation, and survival [5,19,23].”
- Curcumin, a component of golden spice: from bedside to bench and back. (2014, background): “Themaximum absorption (λmax) of curcumin inmethanol occurs at 430 nm (Aggarwal et al., 2003; Goel et al., 2008).”
- A Review of Curcumin and Its Derivatives as Anticancer Agents (2019, neutral): “(turmeric) [5] and was extracted from turmeric plant in a pure crystalline form for the first time in 1870 [6].”